Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CY1
Lin, KM1
O'Suilleabhain, P1
Giller, C1
White, B1
Day, C1
Degenhardt, L1
Kinner, S1
Fry, C1
Bruno, R1
Johnston, J1

Reviews

1 review available for n-methyl-3,4-methylenedioxyamphetamine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Health consequences of illegal drug use.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Amphetamine; Depressive Disorder; Health Status; Hepatitis C; Humans; Illicit Drugs; Marijuana Abuse

2009

Other Studies

2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:11

    Topics: Adult; Antiparkinson Agents; Disease Progression; Hallucinogens; Hepatitis C; Humans; Indoles; Male;

2003
Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    Drug and alcohol dependence, 2006, Jul-27, Volume: 83, Issue:3

    Topics: Adult; Amphetamine-Related Disorders; Australia; Comorbidity; Cross-Sectional Studies; Female; Hallu

2006